Skip to main content

Advertisement

Log in

Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Object

Our purpose in conducting this study was to determine the efficacy of tranexamic acid (TXA) in reducing blood loss in patients after cesarean section (CS).

Method

A randomized, double-blind, case-controlled study was conducted on 174 primipara undergoing CS. 88 of them given 10 mg/kg TXA immediately before CS were compared with 86 others to whom TXA was not given. Blood loss was calculated from blood collected and measured during two periods: the first period was from placental delivery to end of CS and the second from the end of CS to 2 h postpartum. Vital signs such as BP, HR, RP, hemoglobin, platelet count, postoperative PT and PPT were tested in the two groups.

Results

Blood loss in the period between the end of CS and 2 h postpartum was significantly lower (p < 0.01) in the TXA group (46.6 ± 42.7) than in the control group (84.7 ± 80.2). The quantity of total blood from placental delivery to 2 h postpartum was also significantly reduced (p = 0.02) in the TXA group (379.2 ± 160.1) than in the control group (441.7 ± 189.5). However, the amount of blood loss in the period from placental delivery to the end of CS did not differ between the TXA and control groups (p = 0.17). PPH stopped in 65 women (75.6 %) in the control group and in 81 (92.0 %) in the TXA group (p < 0.01). No significant abnormal vital signs were observed after TXA administration. Mild, transient side effects occurred more often in the TXA group than in the control group.

Conclusion

Treatment with TXA is effective in reducing blood loss in patients undergoing CS. Although the study was not adequately powered to address safety issues, the observed side effects were mild and transient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. WHO (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta. Available from: http://whqlibdoc.who.int/publications/2009/9789241598514_eng.pdf

  2. Affairs, U.N.D.o.E.a.S (2010) The millennium development goals report 2010. Available from: http://mdgs.un.org/unsd/mdg/Resources/Static/Products/Progress2010/MDG_Report_2010_En_low%20res.pdf

  3. WHO (2005) World Health Report 2005: Chap 4—make every mother and child count. Available from: http://www.who.int/whr/2005/chap4-en.pdf

  4. Bonnar J (2000) Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 14(1):1–18

    Article  PubMed  CAS  Google Scholar 

  5. Kambo I et al (2002) A critical appraisal of cesarean section rates at teaching hospitals in India. Int J Gynaecol Obstet 79(2):151–158

    Article  PubMed  CAS  Google Scholar 

  6. Goobie SM et al (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114(4):862–871

    Article  PubMed  CAS  Google Scholar 

  7. Okamoto S, Okamoto U (1962) Amino-methyl-cyclohexane-carbolic acid: AMCHA. A new potent inhibitor of fibrinolysis. Keio J Med 11:105–115

    Google Scholar 

  8. Henry DA et al (2011) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 3:CD001886

    PubMed  Google Scholar 

  9. Shakur H et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32

    Article  PubMed  CAS  Google Scholar 

  10. Roberts I et al (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377(9771):1096-101–1101-e12

    Article  Google Scholar 

  11. World Health Organization (2011) Summary of the report of the 18th meeting of the WHO Expert Committee on the selection and use of essential medicines. Available from: http://www.who.int/selection_medicines/committees/expert/18/en/index.html

  12. Gai MY et al (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112(2):154–157

    Article  PubMed  CAS  Google Scholar 

  13. Yang H, Zheng S, Shi C (2001) Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loss: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 36(10):590–592

    PubMed  CAS  Google Scholar 

  14. Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57(6):1005–1032

    Article  PubMed  CAS  Google Scholar 

  15. Ferrer P et al (2009) Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 9:29

    Article  PubMed  Google Scholar 

  16. Gungorduk K et al (2011) Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 28(3):233–240

    Article  PubMed  Google Scholar 

  17. Peitsidis P, Kadir RA (2011) Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 12(4):503–516

    Article  PubMed  CAS  Google Scholar 

  18. Novikova N, Hofmeyr GJ (2010) Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 7:CD007872

    PubMed  Google Scholar 

  19. Movafegh A, Eslamian L, Dorabadi A (2011) Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet 115(3):224–226

    Article  PubMed  CAS  Google Scholar 

  20. Ducloy-Bouthors AS et al (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15(2):R117

    Article  PubMed  Google Scholar 

  21. Kagoma YK et al (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123(5):687–696

    Article  PubMed  CAS  Google Scholar 

  22. Bekassy Z, Astedt B (1990) Treatment with the fibrinolytic inhibitor tranexamic acid—risk for thrombosis? Acta Obstet Gynecol Scand 69(4):353–354

    Article  PubMed  CAS  Google Scholar 

  23. Svanberg L, Astedt B, Nilsson IM (1980) Abruptio placentae—treatment with the fibrinolytic inhibitor tranexamic acid. Acta Obstet Gynecol Scand 59(2):127–130

    Article  PubMed  CAS  Google Scholar 

  24. Gohel M, Patel P, Gupta A, Desai P (2007) Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. J Obstetr Gynecol India 57(3):227–230

    Google Scholar 

Download references

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yingnan Ju.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, J., Gao, W. & Ju, Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet 287, 463–468 (2013). https://doi.org/10.1007/s00404-012-2593-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2593-y

Keywords

Navigation